ANDA 205779, held by Eugia Pharma. Vancomycin Hydrochloride.
As of Nov 16, 2026, ANDA 205779 (Vancomycin Hydrochloride), held by Eugia Pharma, was first approved by FDA on Mar 29, 2016, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 29, 2016 | Original application | Approved | None posted |
| Vancomycin HydrochlorideEQ 5GM BASE/VIAL · injectable;injection | Vancomycin Hydrochloride | Rx |
| Vancomycin HydrochlorideEQ 10GM BASE/VIAL · injectable;injection | Vancomycin Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters